Ganesh Kambhampati, M.D., M.S., FASN

Ganesh Kambhampati, M.D.
Address:

333 University Avenue, Suite 120
Sacramento, CA 95825
Ph: (916) 929-8564
Fax: (916) 929-4529

520 Cottonwood St, Suite 2
Woodland, CA 95695
Ph: 530-668-3600
Fax: 530-668-3601

Education:
  • Nephrology Fellowship
    Division Nephrology, Hypertension and Renal Transplantation
    University of Florida, Gainesville, FL
    2012
  • Master of Science (MS)
    MS in Medical Sciences with a concentration in Clinical Investigation,
    University of Florida, Gainesville, FL
    2012
  • Internal Medicine Residency, MD
    Jacobi Medical Center, Albert Einstein College of Medicine, NY
    2009
  • Research Associate
    Albert Einstein Cancer Center, NY
    2006
  • Post Graduate Certification
    Accident and Emergency Care
    Apollo Hospitals, Hyderabad, India
    2005
  • Medical School
    Bachelor of Medicine and Bachelor of Surgery
    Osmania Medical College, NTR University of Health Sciences
    Hyderabad, India
    2002
Board Certifications:
  • Diplomate of the American Board of Internal Medicine
    2010
  • ABIM/Nephrology Board Certification
    2012
  • Fellow of American Society of Nephrology (FASN)
    2013
Medical Licensure:
  • Full Medical Licensure in the state of California
    2011 - Present
Professional Experience:
  • Consultant Nephrologist
    Capital Nephrology Medical Group
    333 University Avenue, Suite 120
    Sacramento, CA 95825
    2013 - Present
  • Staff Nephrologist
    Division of Nephrology, Hypertension and Renal Transplantation
    Department of Medicine
    Bay Pines VA Health Care System (BP VAHCS)
    Bay Pines, FL 33744
    2012 - 2013
  • Adjunct Clinical Assistant Professor
    Division of Nephrology
    University of Florida College of Medicine
    Gainesville, FL 32610
    2012 - 2013
  • Consultant Nephrologist, Part-Time Physician
    Suncoast Medical Clinic, St Petersburg, FL
    2013
Staff Privileges:
  • Sutter Medical Center
  • Sutter Davis Hospital
  • Woodland Memorial Hospital
  • Mercy General Hospital
  • Mercy San Juan Hospital
  • Mercy Folsom Hospital
  • Methodist Hospital
  • Marshall Hospital
Appointments:
  • Medical Director – Capital Nephrology Clinical Research Division
  • Medical Director – DaVita Broadway Dialysis Clinic, Sacramento, CA
Awards:
  • Finalist / Winner
    Robert Geronemus Memorial Renal Fellows Research Competition
    Florida Society of Nephrology (FSN), Ritz Carlton, Sarasota
    2011
PROFESSIONAL MEMBERSHIP
AND SOCIETIES
Member:
  • American Society of Nephrology (ASN)
  • National Kidney Foundation (DKF)
  • American Medical Association (AMA)
  • American College of Physicians (ACP)
  • International Society of Peritoneal Dialysis (ISPD)
  • Renal Physicians Association (RPA)
  • Institutional Review Board Subcommittee Appointment
    2012 - 2013
  • Voting Member, Bay Pines VA HCS

Clinical Interests:
  • Acute Kidney Injury
  • Glomerulonephritis
  • Hypertension
  • Kidney Stones
  • Anemia
  • Gout
  • Chronic Kidney disease

GRANTS/PUBLICATIONS/
PRESENTATIONS

Research/Clinical Trial:
  1. Wearable Cardioverter Defibrillator study in Hemodialysis patients, Capital Nephrology Medical Group, Kambhampati G Principal Investigator, Sponsor ZOLL
  2. Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis, Capital Nephrology Medical Group, Kambhampati G Principal Investigator, Sponsor Astra Zeneca
  3. Phase 3, Multicenter, Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Dialysis patients. Capital Nephrology Medical Group, Kambhampati G Principal Investigator, Sponsor Astra Zeneca
  4. KRX-0502-306 - A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia in Adult Subjects with Non-Dialysis Dependent Chronic Kidney Disease, Capital Nephrology Medical Group, Kambhampati G Sub- Investigator, Sponsor: Keryx Biopharmaceuticals, Inc.
  5. ZS-005 - A Phase 3 Multicenter, Multi-dose, Open-label Maintenance Study to Investigate the Long-term Safety and Efficacy of ZS (Sodium Zirconium Cyclosilicate), an Oral Sorbent, in Subjects With Hyperkalemia, Including a Randomized, Double-blind, Placebo-controlled, Withdrawal Study, Capital Nephrology Medical Group, Kambhampati G Sub- Investigator, Sponsor: ZS Pharma.
  6. 28431754DNE3001-Phase 3 Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy, Capital Nephrology Medical Group, Kambhampati G Sub- Investigator, Sponsor: Janssen Research & Development.
  7. D5613C00001 A Phase 2b, Randomized, Double blind, Placebo-controlled, Parallel group, Multicentre Dose finding Study to evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis, Capital Nephrology Medical Group, Kambhampati G Sub- Investigator, Sponsor: Astra Zeneca AB.
  8. VPI-CLN-201-AD: A Randomized Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes, Capital Nephrology Medical Group, Kambhampati G Sub- Investigator, Sponsor: Vascular Pharmaceuticals, Inc.
  9. 2012-02-02-NVO-MIA Randomized Controlled Study of the Effect of a Needle Phobia Intervention With or Without Synera® on Conversion from Central Venous Catheters to Arteriovenous Fistula or Graft, Capital Nephrology Medical Group, Kambhampati G Sub- Investigator, Sponsor: DaVita Clinical Research.
  10. AMAG-FER-CKD-401: Ferumoxytol for Anemia of CKD Trial (FACT): A Phase IV, Open-Label, Multicenter Trial, With MRI Substudy, of Repeated Doses of Ferumoxytol Compared With Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA) in Chronic Kidney Disease (CKD) Patients on Hemodialysis, Capital Nephrology Medical Group, Kambhampati G Sub- Investigator, Sponsor: AMAG Pharmaceuticals, Inc.
  11. MK-3102-019 - A Phase III, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of MK-3102 Versus Placebo in Subjects with Type 2 Diabetes Mellitus with Moderate or Severe Chronic Kidney Disease or Kidney Failure on Dialysis Who Have Inadequate Glycemic Control, Capital Nephrology Medical Group, Kambhampati G Sub- Investigator, Sponsor: Merck.
  12. Kambhampati G, Ejaz AA: Investigation of the effects of post-operative fluid balance on inflammatory mediators in patients undergoing cardiovascular surgery. University of Florida, Gainesville, Principal Investigator, intramural funding, 2010-2012. Clinical Trials.gov. Identifier: NCT01168583
  13. Kambhampati G, Hsu S: Epidemiology of renal disease from 1978 to 2008 based on review of Renal Biopsy Databases at Shands UF, Shands AGH, and VA Gainesville. University of Florida, Gainesville, Co-Investigator, intramural funding, 2010-2012.
Peer Revised Publications:
  1. Kambhampati G, Ejaz NI, Asmar A, Aiyer R, Arif AA, Pourafshar N, Yalamanchili YR, Ejaz AA. Fluid Balance and Conventional and Novel Biomarkers of Acute Kidney Injury in Cardiovascular Surgery. J Cardiovasc Surg. 2013
  2. Alsabbagh MM, Asmar A, Ejaz NI, Aiyer R, Kambhampati G, Ejaz AA. Update on clinical trials for the prevention of acute kidney injury in cardiac surgery patients. Am J Surg 2013
  3. Nonobstructive hydronephrosis from social polydipsia: a case report. Maroz N, Maroz U, Iqbal S, Aiyer R, Kambhampati G, Ejaz AA. J Med case Report. 2012 J Med Case Rep. 2012 Nov 6; 6(1):376. PMID: 23130747
  4. Post-operative serum uric acid and acute kidney injury Ejaz AA, Kambhampati G, Ejaz NI, Das B, Lapsia V, Arif AA, Asmar A, Shimada M, Alsabbagh MM, Aiyer R, Johnson RJ.J Nephrol. 2012 PMID: 22684655
  5. Fluid balance as an early indicator of acute kidney injury in CV surgery. Dass B, Shimada M, Kambhampati G, Ejaz NI, Arif AA, Ejaz AA. Clin Nephrol. 2012 PMID: 22595385.
  6. Lowering serum uric acid to prevent acute kidney injury Efaz AA, Dass B, Kambhampati G, Ejaz NI, Maroz N, Dhatt GS, Arif AA, Faldu C, Lanaspa MA, Shah G, Johnson RJ. Med Hypothesis 2012 PMID: 22503466
  7. Perioperative fluid balance and acute kidney injury Kambhampati G, Ross EA, Alsabbagh MM, Asmar A, Pakkivenkata U, Ejaz NI, Arif AA, Ejaz AA. Clin Exp Nephrol. 2012 PMID: 22457087
  8. Elevated uric acid increases the risk for acute kidney injury Lapsia V, Johnson RJ, Das B, Shimada M, Kambhampati G, Efaz NI, Arif AA, Ejaz AA, Am J Med 2012 Mar PMID: 22340933
  9. Anaerobic clavicular osteomyelitis following colonoscopy in a hemodialysis patient. Kambhampati G, Asmar A, Pakkivenkata U, Ather IS, Ejaz AA. Clin Exp Nephrol. 2011 May 28. PMID: 21618076.
  10. Valacyclovir Neurotoxicity Can Be Effectively Managed by Hemodialysis, Kambhampati G, Pakkivenkata U, Kazory A. Eur J Neurol. 2011 Mar, 18. Epub 2010 Nov 18. PMID: 21087359.
  11. The Human and Murine Kidney shows Gender and Species-Specific Gene Expression Differences in Response to Injury, Si H, Banga RS, Kapitsinou P, Ramaiah M, Lawrence J, Kambhampati G, Gruenwald A, Bottinger E, Glicklich D, Tellis V, Greenstein S, Thomas DB, Pullman J, Fazzari M, Susztak K. PLos One. 2009:4(3):e4802. Epub 2009 Mar 11. PMID: 19277126
  12. Frontal Sinus Mucopyocele Ada S, Yalamanchili M, Kambhampati G, Arch Intern Med. 2002 Nov 25;162(21):2487-8. PMID: 12437409
Abstract/Posters:
  1. Scleroderma Renal Crisis versus Atypical Hemolytic Uremic Syndrome. G Kambhampati and A. Ahsan Ejaz. Submitted. American Society of Nephrology Annual Meetings, Atlanta, 2013.
  2. Serum uric acid associated with novel and conventional biomarkers of acute kidney injury A. Ahsan Ejaz, MD, FASN, Noel I. Ijaz, G Kambhampati, MD, Bhagwan Dass, MD, FASN, Vijay Lapsia, MD, Michiko Shimada, MD, PhD, FASN, S. Lanapsa and Richard Johnson, MD. ERA EDTA Annual Meetings, Istanbul, 2013. Submitted
  3. Ejaz AA, Kambhampati G, Ejaz NI, Dass B, Lapsia V, Arif AA, it al. Comparison of serum uric acid and biomarkers to predict acute kidney injury. 49th European Renal Association-European Dialysis, May 24-27 2012.
  4. Fluid Balance and acute kidney injury: a prospective observational study. Kambhampati G, Pakkivenkata U, Abouhamze A, Alsabbagh MM, Asmar A, Dhatt GS, Ather IM, Ejaz IE, Gattas J, Arif AA and Efaz AA. ASN abstract, [FR-PO1067] American Society of Nephrology Annual Meetings, Philadelphia, 2011.
  5. Comparison of Clinical, Biochemical and Biomarker Predictors of Acute Kidney Injury in Cardiac Surgery. Kambhampati G, Alsabbagh MM, Dhatt GS, Pakkivenkata U, Ejaz
  6. AA. ASN abstract, [TH-PO0631] American Society of Nephrology Annual Meetings, Philadelphia, 2011.
  7. Perioperative serum uric acid affects serum NGAL concentrations. Ejaz AA, Asmar A, Shimada M, Kambhampati G, Efaz NI, Arif AA, Alsabbagh M, Johnson RF. ASN abstract, [FR-PO1057] American Society of Nephrology Annual Meetings, Philadelphia, 2011
  8. Elevated uric acid increases the risk for acute kidney injury, hospital stay and duration of mechanical ventilation in cardiac surgery patients. Lapsia V, Johnson RJ, Dass B, Kambhampati G, Ejaz NI, Arif AA, Ejaz AA. World Congress of Nephrology (WCN), April 2011
  9. Hyponatremia after head injury: A complex cerebro-renal connection beyond SIADH. Pakkivenkata U, Kambhampati G, Kazory A. Hyponatremia after head injury: National Kidney Foundation (NKF), April 2011
  10. Co-existent P-ANCA and Anti-GBM Antibody Glomerular Disease associated with Endometrial Cancer. Dass B, Kambhampati G, Kazory A. National Kidney Foundation (NKF), April 2010
  11. Ejection Fraction, Kidney Function and Arrhythmias in patients with Automated Internal Cardiac Defibrillators. Sharma S, Kambhampati G, Acharya A. American Society of Nephrology (ASN), October 2009
  12. “When chest x-ray shows more than lungs” Kambhampati G, Burger A, Society of General Internal Medicine (SGIM) 32nd Annual Meeting, Miami Florida, May 2009

GRAND ROUNDS /
JOURNAL CLUB

  1. Kambhampati G, Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis, Nephrology Journal club, University of Florida, October 2011.
  2. Kambhampati G, Genetic abnormalities of sodium and water transport in the kidney. Renal Grand rounds, Shands Hospital, University of Florida. April 2011.
  3. Kambhampati G, Study of Heart and Renal Protection (SHARP) Trial Nephrology Journal club, University of Florida, March 2011.
  4. Kambhampati G, Fluid Therapy, How much is too much! Renal Grand rounds, Shands Hospital, University of Florida March 2010
  5. Kambhampati G, Dry weight reduction in Hypertensive hemodialysis patients. Nephrology Journal club, University of Florida, September 2009.

Our Locations

CNMG

Capital Nephrology Medical Group

333 University Av., Suite 120

Sacramento, CA 95825

Tel: 916-929-8564

Fax: 916-929-4529



View Office Locations in a larger map

We care about your and your family members' health and helping you make wise care decisions.

Understanding what kind of care you and your family members need is important.

If you think you or your family member has a medical or psychiatric emergency, call 911 or go to the nearest hospital. Do not attempt to access emergency care through this website.